|
|
Office Locations:
|
Novartis Global Research Headquarters
181 Massachusetts Avenue
Cambridge, MA 02139
| |
|
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
Medical Device
Software & Internet
|
|
|
|
dRx Capital is a joint venture capital investment firm launched by Novartis and Qualcomm. The firm seeks to invest in the pharmaceuticals, digital medicine products, mobile, information technology and digital health sectors. Investments span every aspect of business: from research and development, to manufacturing and supply chain, through commercial, medical, and patient care.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
